可可可可改善了粉状β诱导的认知和非认知障碍
Hamid Shokati Basir1, Naser Mirazi1, Alireza Komaki2
1Department of Biology, Faculty of Basic Science, Bu-Ali Sina University, Hamedan, Iran.
Neuroscience insights
|September 24, 2024
概括
在阿尔茨海默病 (AD) 动物模型中,可可消费改善了认知和非认知功能. 它减少了氧化应激和神经元死亡,这表明AD的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经系统疾病,导致认知和非认知障碍.
- 粉样蛋白β (Aβ) 注射模型AD,诱导氧化应激和神经元损伤.
研究的目的:
- 在AD动物模型中研究可可对认知和非认知表现的影响.
- 确定氧化应激在可可对抗AD的潜在治疗作用中的作用.
主要方法:
- 在Aβ诱导的AD大鼠模型中,给药可可 (0.5g/kg/天) 持续60天.
- 评估行为 (运动,焦虑,记忆) 和测量氧化应激标志物 (TOS,TAC).
- 使用血素和色素染色检查海马体神经元健康状况.
主要成果:
- Aβ注射会影响记忆力,增加焦虑,氧化应激和神经元死亡.
- 可可治疗逆转了记忆力缺陷,减少了焦虑,并改善了氧化平衡.
- 可可的管理减少了关键海马区域的神经元死亡.
结论:
- 在AD模型中,可可显示出神经保护作用.
- 改善氧化剂-抗氧化剂平衡和减少神经元损失是可可的潜在益处机制.
- 可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可可
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
107
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
107
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Cognitive Development During Adulthood
66
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
66


